Respiratory Infections News

The FDA has expanded the approval of baloxavir marboxil to include postexposure prophylaxis for influenza in patients aged 12 years or older who have had contact with an infected person.

The Infectious Diseases Society of America said it will continue to recommend remdesivir for patients with severe COVID-19 despite a guideline from WHO last week that recommended against its use in any hospitalized patients.

An interim analysis of clinical trial results in the United Kingdom and Brazil showed that a COVID-19 vaccine candidate codeveloped by AstraZeneca and Oxford University had an average efficacy of 70% with no significant safety concerns.

New data from a systematic review and meta-analysis indicated that the prevalence of HIV was higher among patients hospitalized for COVID-19 than in the general population.

At least 51 people in Minnesota developed COVID-19 after attending a 10-day motorcycle rally in the neighboring state of South Dakota, according to data published in MMWR.

The FDA granted emergency use authorization for the monoclonal antibodies casirivimab and imdevimab to be administered together intravenously for the treatment of mild to moderate COVID-19.

For 5 straight years, the United States hit record highs in reported cases of chlamydia, gonorrhea and syphilis.

According to the CDC, SARS-CoV-2 is mostly spread during close contact with an infected person via respiratory droplets and can sometimes be spread by airborne transmission.

My interest and career choice in infectious diseases intertwine with a personal life journey that spans across three continents.

All clinicians, even those who do not immediately provide COVID-19 vaccines upon their FDA approval, will have a key role in ensuring maximum vaccine uptake, a CDC official said at the virtual Infectious Diseases in Children Symposium.